UA84052C2 - Производное кумарина и его применение - Google Patents

Производное кумарина и его применение

Info

Publication number
UA84052C2
UA84052C2 UAA200609517A UAA200609517A UA84052C2 UA 84052 C2 UA84052 C2 UA 84052C2 UA A200609517 A UAA200609517 A UA A200609517A UA A200609517 A UAA200609517 A UA A200609517A UA 84052 C2 UA84052 C2 UA 84052C2
Authority
UA
Ukraine
Prior art keywords
linear hydrocarbon
benzene ring
hydrocarbon group
carboxyl group
optionally substituted
Prior art date
Application number
UAA200609517A
Other languages
English (en)
Ukrainian (uk)
Inventor
Шого Маруи
Масаки Огино
Хироюки Тавада
Осаму Ябе
Original Assignee
Такеда Фармасьютикал Компани Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Такеда Фармасьютикал Компани Лимитед filed Critical Такеда Фармасьютикал Компани Лимитед
Publication of UA84052C2 publication Critical patent/UA84052C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/16—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Obesity (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Представленное изобретение касается соли щелочноземельного металла или соли органического амина соединения, представленной формулой [І]:,в которой Rи Rкаждый является атомом водорода, атомом галогена или необязательно замещенной линейной углеводной группой; кольцо А является, необязательно, дополнительно замещенным бензольным кольцом; В является, необязательно, замещенным бензольным кольцом; R является карбоксильной группой или линейной углеводной группой, замещенной карбоксильной группой.
UAA200609517A 2004-03-02 2005-03-01 Производное кумарина и его применение UA84052C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004057920 2004-03-02
PCT/JP2005/003838 WO2005082879A1 (en) 2004-03-02 2005-03-01 Coumarin derivative and use thereof

Publications (1)

Publication Number Publication Date
UA84052C2 true UA84052C2 (ru) 2008-09-10

Family

ID=34909071

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200609517A UA84052C2 (ru) 2004-03-02 2005-03-01 Производное кумарина и его применение

Country Status (16)

Country Link
US (1) US7541478B2 (ru)
EP (1) EP1720850A1 (ru)
JP (1) JP2007526237A (ru)
KR (1) KR20060130189A (ru)
CN (1) CN1950352A (ru)
AU (1) AU2005217335A1 (ru)
BR (1) BRPI0508260A (ru)
CA (1) CA2557162A1 (ru)
CR (1) CR8577A (ru)
IL (1) IL177105A0 (ru)
NO (1) NO20064398L (ru)
RU (1) RU2006134614A (ru)
TW (1) TW200531969A (ru)
UA (1) UA84052C2 (ru)
WO (1) WO2005082879A1 (ru)
ZA (1) ZA200606598B (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2920774B1 (fr) * 2007-09-06 2009-10-30 Galderma Res & Dev Nouveaux derives de n-phenul acatamide, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contentant
CN101747305B (zh) * 2008-11-28 2014-06-18 中国医学科学院药物研究所 硝克柳胺化合物晶v型、其制法和其药物组合物与用途
CN112933101A (zh) * 2017-06-26 2021-06-11 上海日馨生物科技有限公司 苯磷硫胺衍生物、制备方法及其药物组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69315920T2 (de) * 1992-09-04 1998-06-10 Takeda Chemical Industries Ltd Kondensierte heterozyklische Verbindungen, deren Herstellung und Verwendung
JP2002255808A (ja) * 2000-07-13 2002-09-11 Takeda Chem Ind Ltd リピド・リッチ・プラーク退縮剤
KR100866820B1 (ko) 2000-07-13 2008-11-04 다케다 야쿠힌 고교 가부시키가이샤 지질 풍부 플라크 퇴축제
KR20040081123A (ko) 2002-01-11 2004-09-20 다케다 야쿠힌 고교 가부시키가이샤 쿠마린 유도체, 이의 제조 방법 및 용도

Also Published As

Publication number Publication date
TW200531969A (en) 2005-10-01
KR20060130189A (ko) 2006-12-18
CN1950352A (zh) 2007-04-18
CR8577A (es) 2007-01-17
BRPI0508260A (pt) 2007-07-31
EP1720850A1 (en) 2006-11-15
ZA200606598B (en) 2008-02-27
RU2006134614A (ru) 2008-04-10
US7541478B2 (en) 2009-06-02
CA2557162A1 (en) 2005-09-09
US20070197636A1 (en) 2007-08-23
JP2007526237A (ja) 2007-09-13
IL177105A0 (en) 2006-12-10
AU2005217335A1 (en) 2005-09-09
NO20064398L (no) 2006-11-08
WO2005082879A1 (en) 2005-09-09

Similar Documents

Publication Publication Date Title
AU2006232435A8 (en) BCRP/ABCG2 inhibitor
IN2012DN04853A (ru)
ATE401311T1 (de) Kondensierte heterozyklische verbindungen als petidase inhibitoren
PH12014501033A1 (en) Aryl-and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
RS51444B (sr) JEDINJENJA KOJA SADRŽE LAKTAM I NJIHOVI DERIVATI KAO INHIBITORI FAKTORA Xa
HK1069395A1 (en) Phthalazinone derivatives 2,3
HK1099284A1 (en) Fused quinoline derivative and use thereof
DK1285651T3 (da) Melanin-koncentrerende hormon-antagonister
TW200602322A (en) Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs
TW200722422A (en) Heterocyclic compound and organic electroluminescent device using the same
TW200510440A (en) Novel compounds
UA88329C2 (en) Dna-pk inhibitors
MX2010008361A (es) Derivados de arilamida oxazepinopirimidona sustituidos.
TW200609218A (en) Bicyclic compounds
AU7824900A (en) Compounds and methods for inhibiting mrp1
MXPA05013584A (es) Compuesto amina terciaria ciclica.
ATE399168T1 (de) Imidazopyridin-derivate und ihre verwendung als induzierbare no-synthase inhibitoren
UA84052C2 (ru) Производное кумарина и его применение
TW200517387A (en) Compounds exhibiting thrombopoietin receptor agonism
NO20051028L (no) Substituerte tiaziner som materialbeskyttelsesmidler
WO2005075460A3 (en) Pyrrolopyrimidine derivatives for treating proliferative diseases
UA94591C2 (ru) Способ получения производных сартана и промежуточных соединений, пригодных для этого способа
DE60105618D1 (de) Dihydroporphyrinderivate und ihre verwendung
TW200801016A (en) Thienopyridine-2-carboxamide derivatives
MXPA03008725A (es) Medicamentos para hiperactividad vesicular.